Manager, Commercial Operations and Strategy

Ginkgo Bioworks is a publicly traded (NYSE: $DNA), high-growth biotechnology company based in Boston’s Seaport District, that is redesigning the living world to solve some of the globe’s growing challenges in health, energy, food, material, and more. Our mission to “make biology easier to engineer” is poised to disrupt multiple industries by leveraging our innovative data, automation, and scale capabilities in biological engineering. 
In response to the global COVID-19 pandemic, we have launched a new division: Concentric by Ginkgo. We firmly believe that testing is an essential requirement to re-open the economy as quickly and safely as possible. Concentric is the largest provider of K-12 COVID-19 testing. We currently run state-level K-12 testing programs in more than 10 states and some of the nation’s largest school districts. To date, Concentric has sequenced more than 10,000 samples from a variety of sample types, in support of public health. As we continue to scale Concentric by Ginkgo, our work is also evolving and expanding into new and exciting directions.

Responsibilities

• Lead commercial operations for large scale biosecurity programs
• Project manage and launch large scale programs, including pilot design and full scale execution of biosecurity programs. This will require assessment of customer testing needs, planning of delivery operations approach, and coordination of various cross-functional resources
• Develop and convert customer pipeline, including identification of new opportunities within and across customer segments
• Plan scale-up and drive operational excellence with individual clients. This will involve strong stakeholder management, a broad understanding of operations strategies, and detailed planning for high scale biosecurity implementation
• Support and coordinate ongoing operational delivery with third-party partners and internal partners, and field, troubleshoot and escalate client concerns as they arise
• Continually shape the client experience and marketing approaches, as part of a cross functional team
• Tackle the most urgent and immediate problems facing the project as a whole
• Support special projects, as requested
• Occasional travel may be required

Minimum Requirements

• Bachelor’s degree
• 5+ years of professional work experience in consulting, operations, biotech, or public health
• Proven track record of project ownership and/or project management and results orientation in a team setting
• Strong analytical skills, with an ability to develop fact-based and informed opinions
• Experience interpreting data for a non-technical audience
• Excellent communication skills, emotional intelligence and an ability to work across organizational boundaries
• Ability to work effectively with cross-functional teams and mobilize people across the organization, and to learn quickly and thrive in a fast-paced environment
• Proficient financial acumen

Preferred Capabilities and Experience

• Bachelor’s degree in biology or other closely related field
• MBA or advanced degree in Sciences, Public Health or Public Policy
• 2-3 years of biology, chemistry, biotechnology, public health, or other scientific experience (in business or technical role)
• Experience managing or coordinating small teams (3 to 7 people) for project execution

Note on culture: Concentric by Ginkgo is a high energy, positive and fast paced environment where new challenges and opportunities arise every day, so this opportunity is ideal for people who thrive in those kinds of environments, and for people who like lots of variety in their day. There are lots of opportunities to learn and grow. The team is motivated by doing high impact work in service to society. To get a sense of the culture at Ginkgo, read some articles in Grow by Ginkgo, the company magazine we produce, which tells the story of synthetic biology in a Ginkgo-authentic way.
To learn more about Ginkgo, check out some recent press:What is it really like to take your company public via a SPAC? One Boston biotech shares its journey (Fortune)Ginkgo Bioworks resizes the definition of going big in biotech, raising $2.5B in a record SPAC deal that weighs in with a whopping $15B-plus valuation (Endpoints News)Ginkgo Bioworks CEO on scaling up Covid-19 testing: ‘If we try, we can win’ (CNBC)